Panagene Succeeds In Developing “ctDNA Mutation Test” Kit Launching A Total Of 4 Breakthrough Commercial Products For Cancer Diagnostics

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SEOUL, South Korea--(BUSINESS WIRE)--Panagene has been in focus on news of having developed a commercial ctDNA test kits that can detect mutated oncogene through blood test alone. This technology is based on PNA (Peptide Nucleic Acid) and it can detect various mutated oncogenes in real-time.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC